Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (885)	9/1/1999 9:26:00 PM
From: arnie h	Read Replies (1) \| Respond to of 1386

Rick: Don't know whether you've gotten your copy of the Annual report so I wanted to comment that the report is quite clear about securing a partnership for HU211 before going into Phase III trials. This strikes me as being inordinately sensible. Aside from the headache-creating section on Common and Preferred Stock Transactions and a sentence that starts out "A momentus energy derives from ..........", the report is very well written and easy to digest. The group that put it together should feel good about their effort. Cheers, Arnie